Kenneth B. Adler

Corporate Officer/Principal presso North Carolina State University

Consumer Services

Health Technology

Posizioni attive di Kenneth B. Adler

Società	Posizione	Inizio	Fine
North Carolina State University	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Direttore Tecnico/Scientifico/R&S	25/02/2002	-
	Fondatore	20/01/2010	-

University of Vermont

Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Tech/Sci/R&D Officer	1
Founder	1
Corporate Officer/Principal	1

Settori

Consumer Services	3
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Health Technology

Aziende private

Health Technology